118 related articles for article (PubMed ID: 35589568)
1. [Progress in research of 2019-nCoV Omicron variant].
Huang Y; Li YH; Xie SL; Rong ZH; Li BS; Kang M; Deng AP; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):655-662. PubMed ID: 35589568
[TBL] [Abstract][Full Text] [Related]
2. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.
Grabowski F; Kochańczyk M; Lipniacki T
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887
[TBL] [Abstract][Full Text] [Related]
3. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
Ren B; Liao BY; Wang JN; Peng X; Zhou XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
[TBL] [Abstract][Full Text] [Related]
4. [Progress in research of epidemiologic feature and control of SARS-CoV-2 Delta variant].
Du M; Liu M; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1774-1779. PubMed ID: 34814611
[TBL] [Abstract][Full Text] [Related]
5. Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection.
Wu Y; Long Y; Wang F; Liu W; Wang Y
Immun Inflamm Dis; 2022 Dec; 10(12):e733. PubMed ID: 36444634
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
Wang L; Cheng G
J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
[TBL] [Abstract][Full Text] [Related]
7. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.
Yu Y; Yu Y; Zhao S; He D
Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998
[TBL] [Abstract][Full Text] [Related]
8. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2.
Parums DV
Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
CDC COVID-19 Response Team
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
[TBL] [Abstract][Full Text] [Related]
10. Is Omicron the end of pandemic or start of a new innings?
Das S; Samanta S; Banerjee J; Pal A; Giri B; Kar SS; Dash SK
Travel Med Infect Dis; 2022; 48():102332. PubMed ID: 35472451
[TBL] [Abstract][Full Text] [Related]
11. [Progress in research of etiology and epidemiology of 2019-nCoV Omicron variant].
Liao CX; Wang B; Lyu J; Li LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Nov; 43(11):1691-1698. PubMed ID: 36444449
[TBL] [Abstract][Full Text] [Related]
12. [Study of transmissibility of 2019-nCoV Omicron variant in Beijing].
Du J; Wang JM; Wang J; Gao YL; Pang XH; Li G
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Sep; 43(9):1364-1369. PubMed ID: 36117340
[No Abstract] [Full Text] [Related]
13. Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa.
Liu Y; Yu Y; Zhao Y; He D
Int J Infect Dis; 2022 Jul; 120():146-149. PubMed ID: 35462038
[TBL] [Abstract][Full Text] [Related]
14. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
Kannan S; Shaik Syed Ali P; Sheeza A
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
[TBL] [Abstract][Full Text] [Related]
15. Importation of SARS-CoV-2 Omicron variant in Beijing, China.
Li F; Liang Z; Cui S; Lv B; Feng Z; Xu H; Jia L; Yang P; Wang Q; Pan Y; Zhang D
Biosaf Health; 2022 Jun; 4(3):150-153. PubMed ID: 35463809
[TBL] [Abstract][Full Text] [Related]
16. Omicron: the highly mutational COVID-19 variant with immune escape.
Khajotia R
Pan Afr Med J; 2022; 41():84. PubMed ID: 35432693
[TBL] [Abstract][Full Text] [Related]
17. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
18. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City.
Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE
J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
20. Has Omicron Changed the Evolution of the Pandemic?
Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
